openPR Logo
Press release

Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to 2022 - Dominated by Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy Products

02-15-2019 03:47 PM CET | Health & Medicine

Press release from: ReportsnReports

Download Free PDF Sample Papers Now at Biopsy Devices Market https://www.reportsnreports.com/contacts/requestsample.aspx?name=1159148 .

Biopsy devices market report analyzes various types of biopsy devices in market and their adoption patterns. It aims at estimating market size and future growth potential of biopsy devices market for different segments such as product, guidance technique, application, end user, and region. Global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America holds largest share of this market. Asia-Pacific region is expected to witness highest CAGR during forecast period of 2017 to 2022.

The global biopsy devices market is projected to reach USD 2.42 billion by 2022 from USD 1.74 billion in 2017, at a CAGR of 6.8% during forecast period. Significant increase in number of people who have cancer, growing number minimally invasive biopsies, and government initiatives in various countries & global health organizations are major factors responsible for growth of biopsy devices market.

Competitive Landscape
1 Introduction
2 Market Share Analysis
3 Competitive Leadership Mapping
4 Visionary Leaders
5 Innovators
6 Emerging Companies
7 Dynamic Differentiators
8 Competitive Benchmarking
9 Strength of Product Portfolio (25 Players)
10 Business Strategyexcellence (25 Players)

Discount on Biopsy Devices Market Now at https://www.reportsnreports.com/contacts/discount.aspx?name=1159148 .

Biopsy devices market ecosystem comprises of following players, namely, C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (U.S.), and Medtronic plc (Ireland).

Global biopsy devices market segmented into needle-based biopsy instruments, procedure trays, localization wires, and products such as forceps, markers, probes, punches, curettes, and sutures. The needle-based biopsy instruments segment is expected to register highest CAGR during forecast period owing to increasing preference for minimally invasive surgeries and higher preference for needle-based biopsies over open surgical biopsies.

More Information on “Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy) Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy) Guidance (Stereotactic, Ultrasound) & by End User (Hospital) - Global Forecast to 2022” research report can be requested at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1159148 .

The report analyzes the global biopsy devices market by product, guidance technique, application, end user, and region. Based on product, global market is segmented into needle-based biopsy instruments, procedure trays, localization wires, and products. In 2016, needle-based biopsy instruments segment accounted for largest share of global market mainly due to increasing preference for minimally invasive surgeries and higher preference for needle-based biopsies over open surgical biopsies.
Geographically,

The growth of this segment can be attributed to the rising prevalence of cancer, large population in countries such as China and India, improving healthcare infrastructure, increasing healthcare spending and government initiatives, and rising focus of key market players in the region are driving the growth of market in Asia-Pacific.

Same Report is Available Now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1169594 .

ReportsnReports is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Number: + 1 888 391 5441
Email Id - sales@reportsandreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to 2022 - Dominated by Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy Products here

News-ID: 1592861 • Views: 214

More Releases from ReportsnReports

Rising Massively Active Protection System Market by 2019-2025 Focusing on Leadin …
The proliferation of advanced RPGs and ATGMs is of concern to some defense officials and policymakers. These weapons—RPGs in particular—have been particularly popular with insurgents because they are readily available, relatively inexpensive, and require little training. Technical and operational challenges to APS include being able to work under extremely demanding circumstances and compressed timelines, robustness against countermeasures, minimizing the threat to friendly forces and civilians, being compatible with the space
Global Accounts Receivable Software Market share, Challenges and Investment oppo …
Accounts Receivable Software is a cost effective software solution designed by receivable professionals for receivable professionals to achieve the Credit and Accounts Receivable objectives. Accounts Receivable Software Market 2019 research is a professional and in-depth study on the current state of the industry and provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. In 2018, the global Accounts Receivable Software market size was xx million
Food and Beverage Insurance Market is Booming Worldwide to Show Significant Grow …
According to new informative report by ReportsnReports an analytical data of Food and Beverage Insurance Market has recently added to its massive database. The research report is encapsulating different verticals of the businesses. It has been aggregated on the basis of different dynamic aspects of the businesses. This statistical report has been compiled by using primary and secondary research methodologies. Well explained Porter’s five analysis and SWOT analysis have been
Study Report on Wearable Medical Devices Market Heart, Pulse, BP and Sleep, Spor …
Report on wearable medical devices market is segmented into diagnostic and monitoring devices and therapeutic devices. Diagnostic & monitoring devices segment is expected to register highest CAGR during forecast period. Get Sample at https://www.reportsnreports.com/contacts/requestsample.aspx?name=781851 . Key players in wearable medical devices market are Fitbit (US), Philips (Netherlands), LifeWatch (Switzerland), Garmin (Switzerland), and Omron (Japan). Other players operating in wearable medical devices market include Drägerwerk (Germany), Nokia Technologies (US), Jawbone (US), Polar

All 5 Releases


More Releases for Biopsy

Liquid Biopsy Market
Liquid biopsies are non-invasive blood tests that detect tumor DNA & RNA fragments and circulating tumor cells (CTCs), which are released into the blood from the primary tumors and metastatic sites. It is a minimally invasive technology for the detection of molecular biomarkers, excluding expensive or invasive procedures. The global liquid biopsy market accounted for $634 million in 2016, and is estimated to reach
Prostate Biopsy Forceps Market
Global Prostate Biopsy Forceps Market Status and Trend Report offers a comprehensive analysis on Prostate Biopsy Forceps industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Browse Full Report with TOC: http://orbisresearch.com/contacts/request-sample/2072536 Key questions answered by this report include: Worldwide and Regional Market Size of Prostate Biopsy Forceps 2013-2017,
Needle Biopsy Industry 2018, Market Structure - By Type Fine-Needle Aspiration B …
Needle Biopsy Market information: by type (fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy, image-guided biopsy) by utility (disposable, reusable), by applications (tumor, infection, Inflammation, others) - Global Forecast till 2023. Considering all these factors the market for Needle Biopsy is expected to reach $ 677 million by the end of 2023, this market is projected to be growing at a CAGR of ~ 5.2 % during 2017-2023. KEY PLAYERS OF NEEDLE
Liquid Biopsy Market - Insights
Liquid biopsy involves testing of the blood to identify biomarkers or cancer cells in the form of cells or pieces of DNA which are separated from the tumor and are circulating in the blood. Liquid biopsy helps in early detection of cancer, which would aid in adopting an optimal treatment plan. It is a non-invasive technique, which makes frequent testing possible, and effectiveness of cancer treatment can also be validated
Biopsy Devices Market
ReportsWorldwide has announced the addition of a new report title Biopsy Devices Market to its growing collection of premium market research reports. This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for biopsy devices. Visit Meddevicetracker to view the latest analysis and updates for the biopsy devices market. Topics Covered Include: An overview of biopsy devices, including biopsy guidance systems, needle-based biopsy products, and other biopsy devices
Liquid Biopsy Market Liquid Biopsy Technology Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Liquid Biopsy: A Non-Invasive, Game-Changer Diagnostic Tool 2. Mechanism of Action: Major Components of Liquid Biopsy 2.1 Circulating Tumor Cells 2.1.1 Parameters Guiding Circulating Cell Tumors 2.2 Circulating Tumor Nucleic Acids (ctNA) 2.2.1 Cell-Free Tumor DNA 2.2.2 Other Circulatory Tumor Nucleic Acid: microRNA, mRNA & Long Non-Coding